AB核心债券主动型ETF CORB 深 沪
等待开盘 02-20 09:30:00 美东时间
30.13
0.000
0.00%
华盛通- 最 高30.18
- 今 开30.14
- 成交量 58.79万股
- 最 低 30.12
- 昨 收 30.13
- 总市值 9.09亿
- 52周最高 30.21
- 市盈率 静 --
- 换手率 1.95%
- 52周最低 29.6076
- 委 比 0.00%
- 总股本 3016.80万
- 历史最高 30.21
- 量 比 8.14
- 振 幅 0.20%
- 历史最低 29.639
- 每 手 1
- 风险率 0.11%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多BRIEF-Corbus Pharmaceuticals Reports Results From Phase 1A Study Of Oral CB1 Inverse Agonist CRB-913 For The Treatment For Obesity Demonstrating Favorable Safety Profile And Emerging Evidence Of Weight Loss
Dec 11 (Reuters) - Corbus Pharmaceuticals Holdings Inc CRBP.O: CORBUS PHARMACEUTICALS REPORTS RESULTS FROM PHASE 1A STUDY OF ORAL CB1 INVERSE AGONIST CRB-913 FOR THE TREATMENT FOR OBESITY DEMONSTRATIN...
2025-12-11 20:47
AllianceBernstein Enhances ETF Offerings with Two New Fixed Income Conversions
NASHVILLE, Tenn., Nov. 10, 2025 /PRNewswire/ -- AllianceBernstein Holding L.P. (NYSE: AB) and AllianceBernstein L.P. ("AB"), a leading global investment management firm, announced today the ...
2025-11-10 20:30
BRIEF-Corbion Signs New Debt Issuance For $100 Million
Nov 7 (Reuters) - Corbion NV CORB.AS: REG-CORBION SIGNS A NEW DEBT ISSUANCE FOR USD 100 MILLION IN THE US PRIVATE PLACEMENT MARKET SIGNING OF A NOTE PURCHASE AGREEMENT FOR A TOTAL DEBT ISSUANCE OF USD...
2025-11-07 14:37
BRIEF-Avita Medical Announces CEO Transition
Oct 17 (Reuters) - AVITA Medical Inc RCEL.O: AVITA MEDICAL ANNOUNCES CEO TRANSITION BOARD CHAIRMAN CARY VANCE APPOINTED INTERIM CEO CARY VANCE APPOINTED INTERIM CEO JIM CORBETT LEAVES POSITIONS AS CEO...
2025-10-17 09:17
BRIEF-FDA Grants Fast Track Status to Corbus Pharma’s Nectin 4 For Head & Neck Squamous Cell Carcinoma Treatment
Sept 16 (Reuters) - Corbus Pharmaceuticals Holdings Inc CRBP.O: FDA GRANTS FAST TRACK DESIGNATION TO CORBUS PHARMACEUTICALS’ NECTIN-4 TARGETING ADC CRB-701 IN HEAD AND NECK SQUAMOUS CELL CARCINOMA Sou...
2025-09-16 20:31
BRIEF-Corbion, Kuehnle Agrosystems Join Forces To Develop Natural Astaxanthin From Algae Fermentation
Aug 19 (Reuters) - Corbion NV CORB.AS: CORBION, KUEHNLE AGROSYSTEMS JOIN FORCES TO DEVELOP NATURAL ASTAXANTHIN FROM ALGAE FERMENTATION Source text: ID:nGNE5C0fH0 Further company coverage: CORB.AS (Gda...
2025-08-19 16:10
BRIEF-Corbus Pharmaceuticals Q2 Basic EPS USD -1.44
Aug 5 (Reuters) - Corbus Pharmaceuticals Holdings Inc CRBP.O: CORBUS PHARMACEUTICALS Q2 NET INCOME USD -17.662 MILLION CORBUS PHARMACEUTICALS Q2 OPERATING EXPENSES USD 19.152 MILLION CORBUS PHARMACEUT...
2025-08-05 21:14
BRIEF-Corbus Pharmaceuticals Announces First Patient Dosed With Its Nectin-4 Targeting ADC CRB-701
June 25 (Reuters) - Corbus Pharmaceuticals Holdings Inc CRBP.O: CORBUS PHARMACEUTICALS ANNOUNCES FIRST PATIENT DOSED WITH ITS NECTIN-4 TARGETING ADC CRB-701 IN COMBINATION WITH PEMBROLIZUMAB CORBUS PH...
2025-06-25 20:22
BRIEF-Corbus Pharmaceuticals' cash runway expected through third-quarter 2027
March 11 (Reuters) - Corbus Pharmaceuticals Holdings Inc CRBP.O: CORBUS PHARMACEUTICALS Q4 NET INCOME USD -9.53 MILLION CORBUS PHARMACEUTICALS Q4 BASIC EPS USD -0.78 CORBUS PHARMACEUTICALS Q4 OPERATIN...
2025-03-11 21:33
